Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 37Carcinoma, Hepatocellular 3Stage II Prostate Adenocarcinoma 1Prostate-specific Membrane Antigen 1Ovarian Neoplasms 1Carcinoma, Lobular 1Carcinoma, Adenoid Cystic 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 2gallium 68 PSMA-11 1BAY 86-7548 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stage II Prostate Adenocarcinoma × gallium 68 PSMA-11 × Clear all
NCT02678351 2022-03-04

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Stanford University

Phase 2/3 Completed
74 enrolled 9 charts
Genitourinary

Stage II Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡